This is an INTERIM report and advises that either TST or QFT be used to determine LTB1 amongst military personnel, hospital staff, and health-care workers whose risk of prior exposure to TB patients is low, and U.S.-born students at certain colleges and universities, recent immigrants, injection-drug users, and residents and employees of high-risk congregate settings (e.g., prisons, jails, homeless shelters, and certain health-care facilities)
This INTERIM report is the guide that health care institutions have been waiting for as it allows them to phase in the CST QFT product eg
"Wisconsin State Laboratory of Hygiene September 24, 2002 1:00 p.m. - 4:30 p.m. 2601 Agriculture Drive
BUSINESS MEETING ITEM #7: PROPOSED NEW TEST TO THE PUBLIC
Description of Item:
As described in the new procedure for "Offering a New Test to the Public," we are notifying the Board of a potential new test.
The Communicable Diseases Division has been requested by the Division of Public Health to bring on- line the QuantiFERON test. This test is for detection of latent TB infection. The DPH would like to offer this test to a selected site (City of Milwaukee TB Clinic) that serves a high risk, medically under-served population. The test would replace the more familiar TB skin test; the new test would not require the patient to return to the clinic to have the skin test evaluated by a clinician. While the DPH will provide funding for this test to be provided by the WSLH at no fee to the selected populations, it is the intention of the TB Prevention and Control Program in Wisconsin to encourage this test to be offered routinely by other laboratories across the state."
GO CST!
CST Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
